Pilot study finds that psilocybin reduces anxiety and improves mood in patients with advanced stage cancer and anxiety.
This pilot study determined that it was feasible and safe to use moderate doses of psilocybin to treat patients with advanced stage cancer and anxiety. The results showed a significant reduction in patient anxiety 1 and 3 months after treatment. Mood improvement was significant after 6 months.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.